Search results
China maintains stance on disputed Gulf islands despite Iran's anger
Reuters via AOL· 6 days agoBEIJING (Reuters) -China held its stance on three disputed islands in the Gulf on Monday despite...
United Arab Emirates | Updates on Tourist-Boosting Initiatives
The National Law Review· 3 days agoThe Emirati government has provided additional details on the new Gulf Cooperation Council tourist...
'An old issue': China, Iran to continue 'strong relations' despite Beijing's stance on disputed Gulf...
South China Morning Post via Yahoo Finance· 5 days agoChina's united call with Abu Dhabi for talks over disputed islands in the Persian Gulf will not...
Airline recovery, ticket prices holding back PHL travel growth – Trip.com
BusinessWorld· 7 days agoThe airline industry recovery and ticket prices remain constraints on hotel and travel industry growth, according to Singapore travel booking service Trip.com Group. Trip.com Assistant Vice-President ...
The Best Everyday Office Perfume for Men
Insider Monkey via Yahoo Finance· 1 day agoIn this article, we will talk about the Best Everyday Office Perfume for Men. For our detailed discussion, go directly to the 15 Best Everyday Office...
Electronic Weapons: Goldeneye Gets A Bigger Ride
Strategy Page· 1 day agoThe UAE also backs a wider program to link ground and air-based surveillance radars of GCC (Gulf Cooperation Council) states (Bahrain ...
A Beloved Regional Chicken Chain Is Expanding With 20 New Locations
Eat This, Not That! via AOL· 2 days agoSlim Chickens / FacebookSlim Chickens, the Arkansas-based fast-casual chain known for its...
KnowBe4 Wins Best Workplaces in Technology™ 2024 Award from Great Place To Work®
PRWeb· 2 days agoTAMPA BAY, Fla., June 7, 2024 /PRNewswire-PRWeb/ -- KnowBe4, the provider of the world's largest security awareness training and simulated phishing platform, announced today that it was recognized ...
Agios Pharmaceuticals Shares Rise 16% After Positive Trial Data for Mitapivat
Market Watch· 5 days agoAgios Pharmaceuticals shares were up 16% to $42 after the company said its global Phase 3 study of mitapivat in adults with transfusion-dependent alpha- or beta-thalassemia achieved its primary ...
Why Is Agios Pharmaceuticals Stock Trading Higher On Monday? - Agios Pharmaceuticals (NASDAQ:AGIO)
Benzinga· 5 days agoShares Agios Pharmaceuticals Inc.’s AGIO climbed after it was revealed a Phase 3 ENERGIZE-T study of...